KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Sarepta Therapeutics (SRPT) over the last 13 years, with Q3 2025 value amounting to 0.39.

  • Sarepta Therapeutics' Asset Utilization Ratio fell 1753.0% to 0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39, marking a year-over-year decrease of 1753.0%. This contributed to the annual value of 0.53 for FY2024, which is 3530.53% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.39 for Q3 2025, which was down 1753.0% from 0.52 recorded in Q2 2025.
  • Sarepta Therapeutics' 5-year Asset Utilization Ratio high stood at 0.52 for Q2 2025, and its period low was 0.2 during Q1 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.32 (2023), whereas its average is 0.35.
  • As far as peak fluctuations go, Sarepta Therapeutics' Asset Utilization Ratio skyrocketed by 4068.14% in 2021, and later plummeted by 1753.0% in 2025.
  • Sarepta Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.24 in 2021, then grew by 22.9% to 0.3 in 2022, then skyrocketed by 31.38% to 0.39 in 2023, then increased by 28.93% to 0.5 in 2024, then dropped by 23.42% to 0.39 in 2025.
  • Its last three reported values are 0.39 in Q3 2025, 0.52 for Q2 2025, and 0.43 during Q1 2025.